id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-294924-5u2tfyd0	Ali, Nurshad	Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?	2020-05-21		.txt	text/plain	1236	70	52	A very recent study included 417 patients reported 76.3% of liver test abnormalities and 21.5% of liver injury among hospitalized COVID-19 patients (Cai et al. The authors observed that patients with elevated liver enzymes in the hepatocyte category had an increasing trend for progression to severe disease course. The prevalence of ALT and AST abnormalities were observed at least two times higher among severe patients than non-severe patients with SARS-CoV-2 infection (Zhao et al. A high prevalence of liver test abnormalities in some studies, suggesting that liver injury in COVID-19 patients might be directly caused by the SARS-CoV-2 infection of liver cells (Cai et al. 2020) , which may partially clarify the contribution of SARS-CoV-2 infection to the liver test abnormalities in COVID-19 patients (Cai et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.	./cache/cord-294924-5u2tfyd0.txt	./txt/cord-294924-5u2tfyd0.txt